Prostate‐specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long‐term survival

This decision-analytic modeling study projects that PSMA-PET/CT-guided management at biochemical recurrence after radical prostatectomy yields a modest survival benefit under the specified model inputs and assumptions regarding treatment distributions. These findings may complement emerging data on the corresponding economic costs and health-related quality of life.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2025-10-18
DOI
https://doi.org/10.1002/cncr.70131
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prostate‐specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long‐term survival

Zizi Elsisi, Lukas Owens, Justin Ferdinandus, Jérémie Calais et al.
Cancer
Prostate Cancer Treatment and Research
article

Prostate‐specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long‐term survival

Zizi Elsisi, Lukas Owens, Justin Ferdinandus, Jérémie Calais, Amir Iravani, Roman Gulati, Yibai Zhao, Vincent P. Laudone, Andrew B. Barbour, Matthew J. Schipper, Wolfgang P. Fendler, Ruth Etzioni, Natalia Kunst, Thomas A. Hope, Alejandro Berlín, Sigrid Carlsson, Jonathan Fainberg, Felipe Montano‐Campos, Kemal Caglar Gogebakan
article en

Abstract

This decision-analytic modeling study projects that PSMA-PET/CT-guided management at biochemical recurrence after radical prostatectomy yields a modest survival benefit under the specified model inputs and assumptions regarding treatment distributions. These findings may complement emerging data on the corresponding economic costs and health-related quality of life.

CancerVol. 131(21)
University Health Network (CA), Memorial Sloan Kettering Cancer Center (US), University of California, Los Angeles (US), University of California, San Francisco (US), University of Washington (US), University of Michigan (US), Princess Margaret Cancer Centre (CA), Yale Cancer Center (US), University of California System (US), Düsseldorf University Hospital (DE), Fred Hutch Cancer Center (US), Integrated Oncology (United States) (US), Essen University Hospital (DE), University Hospital Cologne (DE), Molecular Theranostics (United States) (US), Heinrich Heine University Düsseldorf (DE), University of York (GB), University of Gothenburg (SE)
Openalex Percentile: Top 58%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.